Pancytopenia as a Complication of Low-Dose Methotrexate in a Septuagenarian: A Rare Presentation

Methotrexate (MTX) is an antimetabolite that was initially developed as a chemotherapeutic agent to treat malignancies but later used extensively to treat rheumatological conditions. MTX-induced toxicity is dose- and duration-dependent. Myelosuppression is a rare but fatal complication of MTX that c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cureus
Asıl Yazarlar: Kanderi, Tejaswi, Chan Gomez, Janet, Puthenpura, Max M, Yarlagadda, Keerthi, Gangireddy, Mounika
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cureus 2020
Konular:
Medical Education
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7343297/
https://ncbi.nlm.nih.gov/pubmed/32656010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.8492
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller